Frontiers in Medicine

Papers
(The H4-Index of Frontiers in Medicine is 63. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Deep Learning-Based Decision-Tree Classifier for COVID-19 Diagnosis From Chest X-ray Imaging192
Airway Remodeling in Asthma186
Doctors' adherence to guidelines recommendations and glycaemic control in diabetic patients in Quetta, Pakistan: Findings from an observational study185
Saliva as a Candidate for COVID-19 Diagnostic Testing: A Meta-Analysis170
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2164
Development and Potential Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic Context154
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19146
Acceptability of a COVID-19 Vaccine Among Healthcare Workers in the Kingdom of Saudi Arabia145
Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data143
Extended SIR Prediction of the Epidemics Trend of COVID-19 in Italy and Compared With Hunan, China142
Frequency and Factors Associated With Adverse Events Among Multi-Drug Resistant Tuberculosis Patients in Pakistan: A Retrospective Study142
COVIDNet-CT: A Tailored Deep Convolutional Neural Network Design for Detection of COVID-19 Cases From Chest CT Images141
Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?140
Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis134
Sepsis—Pathophysiology and Therapeutic Concepts128
Treatment of Inflammatory Bowel Disease: A Comprehensive Review125
Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature115
Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic114
Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19112
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review111
Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy107
Serum Biomarkers for Inflammatory Bowel Disease101
Bile Acids and FXR: Novel Targets for Liver Diseases98
Current Update on Intrinsic and Acquired Colistin Resistance Mechanisms in Bacteria98
The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study97
ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Infection in COVID-19 Patients94
Review of Current COVID-19 Diagnostics and Opportunities for Further Development94
SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines94
The Rise and Impact of COVID-19 in India93
Music Therapy in the Treatment of Dementia: A Systematic Review and Meta-Analysis92
Mapping Knowledge Structure and Themes Trends of Osteoporosis in Rheumatoid Arthritis: A Bibliometric Analysis92
IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections91
Defective Mitochondrial Fatty Acid Oxidation and Lipotoxicity in Kidney Diseases91
More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A Scoping Review91
Systematic Review and Meta-Analysis of Sex-Specific COVID-19 Clinical Outcomes90
Secondary Bacterial Infections in Patients With Viral Pneumonia89
COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis87
Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications86
Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings84
Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents84
Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery82
Obesity and Mortality Among Patients Diagnosed With COVID-19: A Systematic Review and Meta-Analysis81
Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment80
COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis77
Artificial Intelligence in Skin Cancer Diagnostics: The Patients' Perspective76
Therapeutic Algorithm for Use of Melatonin in Patients With COVID-1974
Analysis of Ovarian Injury Associated With COVID-19 Disease in Reproductive-Aged Women in Wuhan, China: An Observational Study74
BNT162b2 and ChAdOx1 SARS-CoV-2 Post-vaccination Side-Effects Among Saudi Vaccinees74
Nasopharyngeal Swabs Are More Sensitive Than Oropharyngeal Swabs for COVID-19 Diagnosis and Monitoring the SARS-CoV-2 Load71
Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders71
Artificial Intelligence Applications in Dermatology: Where Do We Stand?71
COVID-19 and the Kidneys: An Update71
Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities68
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?67
Treatment Options for COVID-19: A Review67
The Malnutritional Status of the Host as a Virulence Factor for New Coronavirus SARS-CoV-267
Advances and Trends in Omics Technology Development66
The Impact of Periodontal Disease on Hospital Admission and Mortality During COVID-19 Pandemic66
ACE/ACE2 Ratio: A Key Also in 2019 Coronavirus Disease (Covid-19)?65
HIV Stigma and Discrimination: Perspectives and Personal Experiences of Healthcare Providers in Yogyakarta and Belu, Indonesia64
Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons64
COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin64
Age-Dependent Risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China64
Early Prediction of Sepsis in the ICU Using Machine Learning: A Systematic Review63
Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker63
0.038784027099609